Hyperimed

Hypericum perforatum

No nursery options match these filters

Try another size or variety, or broaden your location. Options with unconfirmed variety names are included when All varieties is selected.

About Hyperimed

A commercial cultivar of Hypericum perforatum included in a 1997–1998 Swiss trial alongside Topas and Elixir. In its first season, Hyperimed showed substantial branching at the base and flower clusters at differing heights. The trial reported vulnerability to anthracnose caused by Colletotrichum gloeosporioides; it should not be treated as a disease-resistant selection.